Similarly, Vercelli scoring, used to assess motor phenotype in ALS mice ( 29 ), showed a trend toward better scores for α5 integrin–treated mice, with a significant difference at week 18 (corresponding to early disease stage) compared to isotype-treated mice ( SI Appendix , Fig.
← all excerpts
Elevated α5 integrin expression on myeloid cells in motor areas in amyotrophic lateral sclerosis is a therapeutic target.
1
—
—